Loading clinical trials...
Loading clinical trials...
A Phase II Trial Of Imatinib Mesylate (Gleevec) In Patients With HIV Related Kaposi's Sarcoma
Conditions
Interventions
imatinib mesylate
Locations
15
United States
Moores UCSD Cancer Center
La Jolla, California, United States
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California, United States
Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California, United States
UCSF Comprehensive Cancer Center
San Francisco, California, United States
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
Start Date
June 1, 2005
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
June 6, 2018
NCT04704661
NCT06066138
NCT05039801
NCT03715933
NCT07479732
NCT07156565
Lead Sponsor
AIDS Malignancy Consortium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions